1. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003. 63:1727–1730.
2. Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene. 2002. 21:6884–6897.
Article
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998. 396:643–649.
Article
4. Nakamura H, Saji H, Idiris A, Hosaka M, Ogata A, Saijo T, Kato H. Chromosomal Instability Detected by Fluorescence in Situ Hybridization in Surgical Specimens of Non-Small Cell Lung Cancer Is Associated with Poor Survival. Clin Cancer Res. 2003. 9:2294–2299.
5. Kang JU, Koo SH, Kwon KC, Park JW, Shin SY, Kim JM, Jung SS. High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization. J Korean Med Sci. 2007. 22:Suppl. S47–S51.
Article
6. Choi CM, Seo KW, Jang SJ, Oh YM, Shim TS, Kim WS, Lee DS, Lee SD. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients. Lung Cancer. 2008. 64:66–70.
Article
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997. 111:1710–1717.
Article
8. Stock C, Ambros IM, Lion T, Haas OA, Zoubek A, Gadner H, Ambros PF. Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer. 1994. 11:40–50.
Article
9. Lee DY, Cho HI, Kang YH, Yun SS, Park SY, Lee YS, Kim Y, Lee DS. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies. Cancer Genet Cytogenet. 2004. 152:1–7.
Article
10. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davis FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004. 64:1546–1558.
11. Pirozynski M. 100 years of lung cancer. Respir Med. 2006. 100:2073–2084.
12. Taguchi T, Zhou JY, Feder M, Litwin S, Klein-Szanto AJ, Testa JR. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet. 1996. 89:120–125.
Article
13. Mendelin J, Grayson M, Wallis T, Visscher DW. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest. 1999. 79:387–393.
14. Kwak KW, Kim SH, Lee HM. The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice. J Korean Med Sci. 2009. 24:1139–1144.
Article
15. Kim SR, Kim HJ, Kim SH. Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia. Korean J Lab Med. 2009. 29:371–378.
Article
16. Yoon YS, Lee DS, Min HC, Jang JY, Lee SE, Hwang DW, Han HS, Kim SW. Analysis of molecular cytogenetics alteration of pancreatic cancer identified by fluorescent in situ hybridization (FISH) and its clinical significance. Korean J Hepatobiliary Pancreat Surg. 2008. 12:75–85.
17. Bubendorf L, Müller P, Joos L, Grilli B, Vogel S, Herzog M, Barascud A, Feichter G, Dalquen P, Tamm M. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol. 2005. 123:516–523.
Article
18. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest. 2006. 130:694–701.
Article
19. Jonsson S, Varella-Garcia M, Miller YE, Wolf HJ, Byers T, Braudrick S, Kiatsimkul P, Lewis M, Kennedy TC, Keith RL, Bjornsson J, McWilliams A, Lam S, Hirsch FR, Franklin WA. Chromosomal Aneusomy in Bronchial High-Grade Lesions Is Associated with Invasive Lung Cancer. Am J Respir Crit Care Med. 2008. 177:342–347.
Article
20. Tseng RC, Hsieh FJ, Hsu HS, Wang YC. Minimal deletion regions in lung squamous cell carcinoma: Association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. Lung Cancer. 2008. 59:332–339.
Article
21. Yakut T, Schulten HJ, Demir A, Frank D, Danner B, Egeli U, Gebitekin C, Kahler E, Gunawan B, Urer N, Oztürk H, Füzesi L. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer. 2006. 54:293–301.
Article